HRO761, a novel, first-in-class clinical stage WRN inhibitor with potent anti-tumor activity in MSI models
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
in vitro study of expression modulation upon WRN inhibition of HRO761 analog 3 treatment
创建时间：
2024-05-17
